Fast Five Quiz: Cellulitis

Mary L. Windle, PharmD


May 22, 2023

The FDA approved delafloxacin, which exhibits activity against both gram-positive and gram-negative pathogens, including methicillin-resistant S aureus, in 2017 for the treatment of ABSSSI. It is available in both intravenous and oral formulations. Daptomycin and vancomycin can treat ABSSSI, but neither is effective against gram-negative pathogens. Nafcillin is effective against gram-positive pathogens only and is not indicated for the treatment of ABSSSI.

Learn more about delafloxacin.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.